Olanzapine Tablet
Product Images NDC 67184-0565

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 67184-0565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))

This text is a prescription information for Olanzapine Tablets, USP containing 2.5 mg of Olanzapine. It provides instructions for storage conditions, dosage information, manufacturer details, and dispensing guidelines for pharmacists. It also reminds to keep the medication out of reach of children and to dispense the accompanying Medication Guide to each patient.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

This information provides details about Olanzapine Tablets, USP with a dosage of 8 mg per tablet. It includes instructions for pharmacists to dispense a medication guide to each patient, advises on storage conditions, and reminds to keep all drugs out of reach of children. The manufacturing details indicate Gl Pharmaceutical Co. Ltd. in Jinan, China. The revision date is August 2018.*

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablets Bottle))

This text is a label for Olanzapine Tablets, USP. It provides instructions for pharmacists regarding dispensing the medication along with the Medication Guide to each patient. The tablets contain 7.6 mg of olanzapine. The typical dosage is provided in the accompanying literature. It further instructs to keep the medication out of reach of children, store at room temperature, protect from light and moisture, and dispense in a tightly closed, light-resistant container. The manufacturing details include Gl Pharmaceutical Co. Ltd. located in Jinan, China. The revision date of the label is August 2018.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

This text includes information about Olanzapine Tablets, USP containing 10 mg of olanzapine. It mentions directions for dosage, storage, and dispensing the accompanying Medication Guide to each patient. The tablets should be stored at room temperature and protected from light and moisture. The text also provides details of the manufacturer - Gl Pharmaceutical Co. Ltd in China.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

This text contains information about Olanzapine Tablets in 15 mg dosage. It is essential to dispense the medication guide to each patient and keep the drug out of the reach of children. The recommended storage guidelines include keeping it tightly closed, avoiding use if the seal is broken, storing at controlled room temperature, and protecting from light and moisture. The tablets are for prescription use only.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablets Bottle))

This text provides information about Olanzapine Tablets, USP containing 20 mg of the active ingredient. It includes directions for storage at a controlled room temperature, protection from light and moisture, and dispensing in a tight, light-resistant container. The text also mentions the accompanying Medication Guide that should be dispensed to each patient by the pharmacist.*

FDA Label Image

Image Description (Olanzapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.